OVID THERAPEUTICS

Serial Number 87337011
Registration 5619979
702

Registration Progress

Application Filed
Feb 15, 2017
Under Examination
Approved for Publication
Jul 18, 2017
Published for Opposition
Jul 18, 2017
Registered
Dec 4, 2018

Trademark Image

OVID THERAPEUTICS

Basic Information

Serial Number
87337011
Registration Number
5619979
Filing Date
February 15, 2017
Registration Date
December 4, 2018
Published for Opposition
July 18, 2017
Drawing Code
4

Status Summary

Current Status
Active
Status Code
702
Status Date
Sep 4, 2024
Registration
Registered
Classes
042

Rights Holder

Ovid Therapeutics Inc.

03
Address
1460 Broadway
New York, NY 10036

Ownership History

Ovid Therapeutics Inc.

Original Applicant
03
New York, NY

Ovid Therapeutics Inc.

Owner at Publication
03
New York, NY

Ovid Therapeutics Inc.

Original Registrant
03
New York, NY

Legal Representation

Attorney
Danny M. Awdeh

USPTO Deadlines

Next Deadline
1041 days remaining
Section 8 & 9 Renewal Due (Principal Register) (Based on registration date 20181204)
Due Date
December 04, 2028
Grace Period Ends
June 04, 2029

Application History

27 events
Date Code Type Description Documents
Sep 4, 2024 NA85 E NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED Loading...
Sep 4, 2024 C15A O REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. Loading...
Sep 4, 2024 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL Loading...
Feb 14, 2024 E815 I TEAS SECTION 8 & 15 RECEIVED Loading...
Dec 4, 2023 REM1 E COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Loading...
Dec 4, 2018 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Oct 25, 2018 TMBN T TTAB RELEASE CASE TO TRADEMARKS Loading...
Oct 25, 2018 OP.T T OPPOSITION TERMINATED NO. 999999 Loading...
Oct 25, 2018 OP.D T OPPOSITION DISMISSED NO. 999999 Loading...
Sep 7, 2017 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Sep 7, 2017 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Jul 25, 2017 OP.I T OPPOSITION INSTITUTED NO. 999999 Loading...
Jul 25, 2017 OPPF T OPPOSITION PAPERS RECEIVED AT TTAB Loading...
Jul 18, 2017 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jul 18, 2017 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jun 28, 2017 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
May 18, 2017 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
May 18, 2017 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
May 18, 2017 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
May 18, 2017 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
May 18, 2017 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
May 17, 2017 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
May 17, 2017 GNRT F NON-FINAL ACTION E-MAILED Loading...
May 17, 2017 CNRT R NON-FINAL ACTION WRITTEN Loading...
May 10, 2017 DOCK D ASSIGNED TO EXAMINER Loading...
Feb 22, 2017 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Feb 18, 2017 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
Pharmaceutical product evaluation for the treatment of rare neurological diseases and disorders; Pharmaceutical products development for the treatment of rare neurological diseases and disorders; Pharmaceutical research and development for the treatment of rare neurological diseases and disorders
First Use Anywhere: Jun 27, 2016
First Use in Commerce: Jun 27, 2016

Classification

International Classes
042

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"THERAPEUTICS"